A detailed history of Tower Research Capital LLC (Trc) transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,202 shares of ENTA stock, worth $52,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,202
Previous 4,928 46.14%
Holding current value
$52,790
Previous $51,000 19.61%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$5.75 - $12.99 $13,075 - $29,539
2,274 Added 46.14%
7,202 $41,000
Q3 2024

Nov 14, 2024

BUY
$10.05 - $16.54 $21,135 - $34,783
2,103 Added 74.44%
4,928 $51,000
Q2 2024

Aug 13, 2024

BUY
$11.43 - $17.02 $14,950 - $22,262
1,308 Added 86.22%
2,825 $36,000
Q1 2024

May 15, 2024

SELL
$10.08 - $17.46 $50,238 - $87,020
-4,984 Reduced 76.67%
1,517 $26,000
Q4 2023

Feb 13, 2024

BUY
$8.18 - $10.78 $2,265 - $2,986
277 Added 4.45%
6,501 $61,000
Q3 2023

Nov 14, 2023

BUY
$11.09 - $22.13 $46,555 - $92,901
4,198 Added 207.21%
6,224 $69,000
Q2 2023

Aug 14, 2023

BUY
$20.68 - $39.85 $18,632 - $35,904
901 Added 80.09%
2,026 $43,000
Q1 2023

May 09, 2023

BUY
$38.82 - $54.59 $30,667 - $43,126
790 Added 235.82%
1,125 $46,000
Q4 2022

Feb 10, 2023

SELL
$40.77 - $53.73 $236,873 - $312,171
-5,810 Reduced 94.55%
335 $15,000
Q3 2022

Nov 10, 2022

SELL
$48.29 - $71.27 $293,168 - $432,680
-6,071 Reduced 49.7%
6,145 $319,000
Q2 2022

Aug 15, 2022

BUY
$38.13 - $76.93 $60,550 - $122,164
1,588 Added 14.94%
12,216 $577,000
Q1 2022

May 12, 2022

BUY
$56.06 - $74.11 $425,102 - $561,976
7,583 Added 249.03%
10,628 $757,000
Q4 2021

Feb 14, 2022

BUY
$60.19 - $97.37 $100,095 - $161,926
1,663 Added 120.33%
3,045 $228,000
Q3 2021

Nov 15, 2021

SELL
$41.02 - $58.65 $369 - $527
-9 Reduced 0.65%
1,382 $79,000
Q2 2021

Aug 16, 2021

SELL
$43.76 - $53.11 $13,171 - $15,986
-301 Reduced 17.79%
1,391 $61,000
Q1 2021

May 17, 2021

BUY
$41.69 - $54.95 $32,184 - $42,421
772 Added 83.91%
1,692 $84,000
Q4 2020

Feb 16, 2021

SELL
$41.16 - $47.47 $16,916 - $19,510
-411 Reduced 30.88%
920 $39,000
Q3 2020

Nov 16, 2020

SELL
$43.36 - $53.53 $73,104 - $90,251
-1,686 Reduced 55.88%
1,331 $61,000
Q2 2020

Aug 13, 2020

BUY
$46.37 - $57.58 $139,898 - $173,718
3,017 New
3,017 $151,000
Q4 2019

Feb 07, 2020

SELL
$57.95 - $66.61 $17,211 - $19,783
-297 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$60.08 - $88.17 $17,843 - $26,186
297 New
297 $18,000
Q2 2019

Aug 13, 2019

SELL
$81.3 - $97.35 $13,089 - $15,673
-161 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$69.08 - $105.66 $11,121 - $17,011
161 New
161 $15,000
Q4 2018

Feb 14, 2019

SELL
$65.41 - $84.65 $65 - $84
-1 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$85.46 - $126.37 $85 - $126
1 New
1 $0

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $152M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.